Researchers find cellular evidence behind lasting immune response in some cancer survivors eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Three new gifts totaling $3.35 million will go toward cancer immunotherapy research and teaching at a New Hampshire cancer center. The funds will help accelerate the development of multiple, promising, next-generation immunotherapies, which harness a patient’s own immune system, at Dartmouth-Hitchcock’s Norris Cotton Cancer Center. Steven Leach, center director, says the drugs take the brakes off the immune system and allows it to recognize and.
By - Associated Press - Sunday, February 7, 2021
LEBANON, N.H. (AP) - Three new gifts totaling $3.35 million will go toward cancer immunotherapy research and teaching at a New Hampshire cancer center.
The funds will help accelerate the development of multiple, promising, next-generation immunotherapies, which harness a patient’s own immune system, at Dartmouth-Hitchcock’s Norris Cotton Cancer Center.
“These drugs take the brakes off the immune system and allow it to recognize, treat and cure a cancer, just as it would an infection,” says Steven Leach, director of the center and the Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer at the Geisel School of Medicine at Dartmouth.
Researchers develop FLASH ultra-high-dose rate radiation therapy beam for cancer treatment
A joint team of researchers from Radiation Oncology at Dartmouth s and Dartmouth-Hitchcock s Norris Cotton Cancer Center (NCCC), Dartmouth Engineering, and Dartmouth-Hitchcock s Department of Surgery have developed a method to convert a standard linear accelerator (LINAC), used for delivery of radiation therapy cancer treatment, to a FLASH ultra-high-dose rate radiation therapy beam. The work, entitled Electron FLASH Delivery at Treatment Room Isocenter for Efficient Reversible Conversion of a Clinical LINAC, is newly published online in the
International Journal of Radiation Oncology, Biology & Physics.
The exceptionally high dose rate is 3,000 times higher than normal therapy treatment (300 Gray per second vs. 0.1 Gray per second, Gray being a standard unit measuring absorbed radiation). Instead of treatment over 20 seconds, an entire treatment is completed in 6 milliseconds, giving the
A joint team of researchers from Radiation Oncology at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC), Dartmouth Engineering, and Dartmouth-Hitchcock’s Department of Surgery have developed a method to convert a standard linear accelerator (LINAC), used for delivery of radiation therapy cancer treatment, to a FLASH ultra-high-dose rate radiation therapy beam. The work, entitled “Electron FLASH Delivery at Treatment Room Isocenter for Efficient Reversible Conversion of a Clinical LINAC,” is newly published online in
International Journal of Radiation Oncology, Biology & Physics.
The exceptionally high dose rate is 3,000 times higher than normal therapy treatment (300 Gray per second vs. 0.1 Gray per second, Gray being a standard unit measuring absorbed radiation). Instead of treatment over 20 seconds, an entire treatment is completed in 6 milliseconds, giving the therapy its nickname, “FLASH.” “These high dose rates have been shown to pro